- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-04-02-2012
Pharmaceutical Technology
Pharmaceutical Technology, April 2012 Issue (PDF)
April 02, 2012
Issue PDF
36
4
Navigating the Equipment and Machinery Market
Navigating the Equipment and Machinery Market
April 02, 2012
Special Reports
36
4
Pharmaceutical Technology's annual survey on equipment and machinery reveals the spending levels and type of spending made in 2011 and planned for 2012.
Evaluating Impurities in Drugs (Part III of III)
April 02, 2012
Peer-Reviewed Research
36
4
In Part III of a three-part article, the authors examine various degradation routes of APIs, impurities arising from interactions in formulations, metabolite impurities, various analytical methods to measure impuritie, and ways to control impurities.
Scale-up Challenges in Hot-Melt Extrusion
April 02, 2012
Troubleshooting
36
4
Critical issues that should be considered when scaling up a hot-melt extrusion process.
A Look at INTERPHEX 2012
April 02, 2012
Guest Editorial
36
4
Collaboration can begin with a conversation.
A Sustainable Biotech Path
April 02, 2012
BioForum
36
4
With financing constrained, biotechnology firms must find ways to sustain innovation.
Ways to Recover Lost Margins
April 02, 2012
Outsourcing Outlook
36
4
Recovery audits and other past practices in procurement can improve the bottom line.
Inside INFORMEX: Evaluating the Market for Contract API Manufacturing
April 02, 2012
Special Features
36
4
Contract API manufacturers and fine-chemical producers roll out capacity and service expansions.
Managing Product Supply Risks
April 02, 2012
Special Features
36
4
How to use geographic diversification and legacy technology transfers to avoid product shortages.
Scoping out INTERPHEX
April 02, 2012
Packaging Forum
36
4
Visitors will see many packaging innovations at the annual industry exhibition.
Loose Lips Sink Ships
April 02, 2012
Agent-in Place
36
4
Failure to disclose info may work sometimes, but eventually every question will be answered.
Clinical Trials of New Medicines
April 02, 2012
Viewpoint
36
4
The importance of new drug trials to patients, the economy, and science.
Representative Sampling
April 02, 2012
Statistical Solutions
36
4
Understanding the differences between convenience, target, and self-selected samples.
Product Quality Lifecycle Implementation
April 02, 2012
Special Features
36
4
The authors provide an overview of the new ISPE Guide Series on Product Quality Lifecycle Implementation and how the guides can be used in a complementary way with existing guidance from FDA and the International Conference on Harmonization.
Compendial Globalization: Achieving Harmonization through Standardized Practices and Collaboration
April 02, 2012
Special Features
36
4
The authors discuss a new approach to address globally harmonized compendial standards.
Q&A with Erik van den Berg, AM-Pharma
April 02, 2012
Industry Leaders
36
4
A Q&A with Erik van den Berg, CEO of AM-Pharma, on recent industry trends.
Freeze-Drying: Is Technology Advancing Fast Enough?
April 02, 2012
Special Reports
36
4
Experts discuss the best practices for developing a QbD-based lyophilization process.
Manufacturers Wrestle with Drug Abuse and Shortages
April 02, 2012
Regulatory Watch
36
4
Soaring opioid use creates challenges for new drug development and supply-chain control.
Inside PIC/S: Top GMP Deficiencies
April 02, 2012
Inside PIC/S
36
4
Comparison of the top GMP deficiencies cited by the PIC/S Participating Authorities.
PDA Tackles Changing Industry Times
April 02, 2012
PharmTech Talk
36
4
The confluence of science, technology, and regulation can provide path forward.
Expanding Excipient Portfolios
April 02, 2012
Pharma Ingredients
36
4
Excipient manufacturers expand production capacity and partner to broaden their offerings.
Report from China
April 02, 2012
In the Field
36
4
China's drug-distribution network has been a mess for years, but government reforms and industry focus are unveiling new opportunities for market order and growth.
Know the Regulations
April 02, 2012
Insider Solutions
36
4
The contract provider needs to know as much as the NDA holder.
Costs of Failure in Product Quality
April 02, 2012
Special Features
36
4
The authors detail the possible consequences of noncompliance and a lack of quality control.
Gaining a Pulse on Formulation and Drug Delivery Challenges and Technologies
April 02, 2012
Special Features
36
4
A recent survey examines the industry's views on the chief challenges and technologies in drug delivery and formulation development.
Regulation and Compliance: Deviation Investigations
April 02, 2012
In the Field
36
4
Q&A with Peter Smith and David Elder, Strategic Compliance Consulting, PAREXEL International, on acceptable deviation investigations. Smith and Elder are both former senior officials with FDA.